๐ŸŽ Black Friday: up to 50% off of annual plans
Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)
Taiwan flag Taiwan ยท Delayed Price ยท Currency is TWD
27.50
-0.90 (-3.17%)
Nov 20, 2026, 1:30 PM CST

TPEX:4111 Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,4341,3761,1651,0611,1431,022
Revenue Growth
5.33%18.11%9.86%-7.19%11.81%4.38%
Gross Profit
560.18543.66397.18343.1422.51356.58
Operating Income
204.43199.398.9361.21153.84119.06
Net Income
186.21164.28110.6368.67154.0180.75
Earnings Per Share
3.072.721.841.142.561.34
EPS Growth
11.76%47.98%60.83%-55.37%90.77%36.85%

Revenue by Geography

Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period EndingDec '24 Dec '23 Dec '22 Dec '21
Taiwan
1,1531,0501,1341,014
Others
12.3310.859.578.36
Total
1,1651,0611,1431,022

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
397.85443.91336.19381.05456.25252.27
Total Debt
17.4123.926.62122.9128.38144
Net Cash (Debt)
380.44420.01309.57258.15327.87108.27
Net Cash Growth
-4.01%35.68%19.92%-21.26%202.84%-66.51%
Net Cash Per Share
6.276.955.154.305.451.80

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
254.82274.61213.274.52214.86139.33
Capital Expenditures
-134.31-93.86-84.19-101.5-105.33-264.86
Free Cash Flow
120.51180.75129.01-26.98109.53-125.53
Free Cash Flow Growth
-18.72%40.11%----

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
39.08%39.50%34.08%32.34%36.96%34.88%
Operating Margin
14.26%14.48%8.49%5.77%13.46%11.65%
Pretax Margin
16.69%15.02%11.82%8.23%14.20%12.89%
Profit Margin
12.99%11.94%9.49%6.47%13.47%7.90%
FCF Margin
8.41%13.13%11.07%-2.54%9.58%-12.28%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
1.3001.3000.9520.9521.1430.952
Dividend Per Share Growth
30.00%36.50%0%-16.67%20.00%0%
Dividend Yield
4.73%4.39%3.60%3.75%4.43%4.33%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
8.9610.7314.3222.1110.0316.30
Forward PE
-15.6215.6215.6213.7714.26
P/FCF Ratio
13.659.7512.28-14.10-
PS Ratio
1.151.281.361.431.351.29